News

WASHINGTON (Sept. 24, 2019) – Breast cancer is the second most commonly diagnosed cancer in women in the United States, with the American Cancer Society predicting more than 250,000 new cases in 2019. October is Breast Cancer Awareness Month and the George Washington University Cancer Center has...

WASHINGTON (Sept. 24, 2019) — PTEN , a tumor suppressor gene mutated in approximately 20% of primary prostate cancers, and in as many as 50% of androgen deprivation-resistant prostate cancers, relies on another gene, ARID4B , to function. These findings were published by George Washington...

WASHINGTON (Aug. 16, 2019) — The extracellular regulated kinase (ERK) protein is an important mechanism behind platinum-resistance in platinum-resistant ovarian cancer, according to a study from a research team at the George Washington University (GW) Cancer Center. The study, which is the first to...

Eduardo Sotomayor, an internationally recognized visionary in the field of lymphoma research and treatment, was recently installed as the inaugural Dr. Cyrus Katzen Family Director of the George Washington University Cancer Center.

An estimated 850,000 to 2.2 million people in the United States are living with Chronic Hepatitis B. A research team from the George Washington University (GW) received a $1.5 million grant from the Office of Minority Health of the U.S. Department of Health & Human Services (HHS) to reduce and...

The George Washington University (GW) is pleased to announce that the GW Biorepository is now a core facility. Housed at the GW School of Medicine and Health Sciences, the GW Biorepository received designation as a shared resource available to all GW investigators and is accredited by the College...

WASHINGTON (August 2, 2019) — Under the leadership of Vishal A. Patel, MD , FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University (GW) Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk...

WASHINGTON, D.C. (July 30, 2019) – Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University (GW) and the GW Cancer Center today announced that Carla J. Berg, PhD, MBA, has been named the associate center director for population sciences and policy for the...

A research team led by Yanfen Hu, PhD , professor of anatomy and cell biology at the George Washington University (GW) School of Medicine and Health Sciences and member of the GW Cancer Center, is studying the role of the tumor suppressor BRCA1 in the homologous recombination pathway of DNA double-...

WASHINGTON (July 9, 2019) — Sun safety practices for attendees at skin cancer screening events differ from the general public, according to findings published by researchers from the George Washington University (GW) Cancer Center. The study was published in the Journal of Drugs in Dermatology...

The George Washington University (GW) Cancer Center recently celebrated Pride Month, a time to recognize and celebrate lesbian, gay, bisexual, transgender, and queer/questioning (LGBTQ+) communities. During pride, we acknowledge history and the past while looking to the future for opportunities to...

WASHINGTON (May 13, 2019) — The George Washington University (GW) Cancer Center is pleased to announce the establishment of the Dr. Cyrus Katzen Family Director of the GW Cancer Center, thanks to a generous gift from GW alumnus and former Board of Trustee member, Jay Katzen, BA ’67, MD ’72 . The...

WASHINGTON (April 30, 2019)—The George Washington University (GW) Cancer Center recently welcomed 12 multidisciplinary health care teams from across the U.S. and territories to its second TEAM (Together, Equitable, Accessible, Meaningful) Training program. The two-and-a-half day program was the...

In the last 25 years, significant progress has been made in the fight against cancer. Even still, cancer remains the second most common cause of death in the United States, according to the U.S. Centers for Disease Control and Prevention — and those in the D.C. area are not immune to its burden.

WASHINGTON (March 27, 2019) – Principal Investigator Mandi Pratt-Chapman, MA has been awarded a $4.125 million cooperative agreement to continue work with the Centers for Disease Control and Prevention (CDC) to provide comprehensive technical assistance for National Comprehensive Cancer Control...

The George Washington University (GW) Cancer Center is pleased to announce that accomplished medical oncologist George Kim, MD, has joined the GW Cancer Center. He will serve as the director of the Gastrointestinal Cancers Program at the GW Cancer Center.

A team at the GW Cancer Center found that the deubiquitinating enzyme USP15 is a potential biomarker for treatments of breast and pancreatic cancers.

The George Washington University (GW) Cancer Center and the GW School of Medicine and Health Sciences (SMHS) will have a large presence at the upcoming American Academy of Dermatology Association (AAD) Annual Meeting. The meeting will be held at the Walter E. Washington Convention Center in...

A team from the George Washington University (GW) Cancer Center has been approved for a $300,000 funding award through the Eugene Washington PCORI Engagement Awards (Engagement Awards) program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).

The George Washington University (GW) Cancer Center is pleased to announce the expansion of the Cutaneous Oncology Multidisciplinary Program. The program will bring together dermatologists, dermatologic surgeons, medical, surgical and radiation oncologists, and pathologists to provide personalized skin cancer care to patients in the District and surrounding region.

A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and potentially prevent cancer metastasis, according to a study published today in Science Translational Medicine.

The GW Cancer Center hosts a monthly breast cancer disparities work group to facilitate connections across the University between researchers, clinicians and members of the community, including survivors and caregivers.

WASHINGTON (Jan. 28, 2018) — A team from the George Washington University (GW) Cancer Center has engineered a nanoimmunotherapy that combines the advantages of nanotechnology and immunotherapy to treat cancer. The goal of this nanoimmunotherapy combination is to increase the potency of immune...

Members of the George Washington University (GW) Cancer Center, including Mandi Pratt-Chapman, MA, associate center director for patient-centered initiatives and health equity, recently published several journal articles and patient-focused pieces highlighting the GW Cancer Center’s work in patient navigation and survivorship.

The George Washington University (GW) Cancer Center is pleased to announce that Vishal A. Patel MD, FAAD, FACMS , an accomplished Mohs/Dermatologic surgeon and cutaneous oncologist, has joined the GW Cancer Center. He will serve as the director of the recently established Cutaneous Oncology Program...